Armstrong’s Entire Cycling Career Fueled by Doping, USADA Says
Seven-time Tour de France winner Lance Armstrong’s entire cycling career was fueled by performance-enhancing drugs, the U.S. Anti-Doping Agency said in a summary of its case against him.
Armstrong also required teammates to use banned substances or he would dismiss them from his squad, the report says. He also paid Michele Ferrari, a physician who played a “major role” in his doping program, $1 million, the report says.
Armstrong, 41, won the Tour de France every year from 1999-2005 with the U.S. Postal Service and Discovery teams.
To contact the editor responsible for this story: Michael Sillup at firstname.lastname@example.org
Bloomberg moderates all comments. Comments that are abusive or off-topic will not be posted to the site. Excessively long comments may be moderated as well. Bloomberg cannot facilitate requests to remove comments or explain individual moderation decisions.